Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cpd-A1 alleviates acute kidney injury by inhibiting ferroptosis.
Chen Y, Wu MF, Xie MM, Lu Y, Li C, Xie SS, Ma WX, Ji ML, Hou R, Dong ZH, He RB, Zhang MM, Lu H, Gao L, Wen JG, Jin J, Dong XW, Che JX, Meng XM. Chen Y, et al. Among authors: dong xw. Acta Pharmacol Sin. 2024 Aug;45(8):1673-1685. doi: 10.1038/s41401-024-01277-w. Epub 2024 Apr 19. Acta Pharmacol Sin. 2024. PMID: 38641746
Mouse nerve growth factor suppresses neuronal apoptosis in valproic acid-induced autism spectrum disorder rats by regulating the phosphoinositide-3-kinase/serine/threonine kinase signaling pathway.
Jian J, Li LG, Zhao PJ, Zheng RJ, Dong XW, Zhao YH, Yin BQ, Li S, Cheng H, Li HL, Li EY. Jian J, et al. Among authors: dong xw. Pharmacogenet Genomics. 2023 Jul 1;33(5):101-110. doi: 10.1097/FPC.0000000000000498. Epub 2023 May 2. Pharmacogenet Genomics. 2023. PMID: 37261937
Pancreatitis and Pancreatic Cancer Risk.
Ma DM, Dong XW, Han X, Ling Z, Lu GT, Sun YY, Yin XD. Ma DM, et al. Among authors: dong xw. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231164875. doi: 10.1177/15330338231164875. Technol Cancer Res Treat. 2023. PMID: 36972517 Free PMC article.
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway).
Jiao XD, Qin BD, Wang Z, Liu K, Wu Y, Ling Y, Qin WX, Wang MM, Yuan LY, Barreto SG, Kim AW, Mak K, Li H, Xu YY, Qiu XM, Wu M, Jin M, Xu LC, Zhong Y, Yang H, Chen XQ, Zeng Y, Shi J, Zhu WY, Ding QQ, Jia W, Liu SF, Zhou JJ, Shen H, Yao SH, Guo ZJ, Li T, Zhou PJ, Dong XW, Lu WF, Coleman RL, Akce M, Akladios C, Puccetti F, Zang YS. Jiao XD, et al. Among authors: dong xw. Front Oncol. 2023 Feb 23;13:860711. doi: 10.3389/fonc.2023.860711. eCollection 2023. Front Oncol. 2023. PMID: 36910668 Free PMC article.
157 results